Named on 3 rounds in the feed, most often at Series B.
Rounds from 2025-04-03 to 2025-12-03
ROUNDS
3
joined, none as lead
ROUNDS JOINED · USD
$342M
across 3 rounds
CO-INVESTORS
29
named beside it
Named on 3 rounds in the feed, most often at Series B.
Rounds from 2025-04-03 to 2025-12-03
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Triana Biomedicines Trianabio sells novel biopharmaceutical therapeutics focused on utilizing molecular glues to treat previously undruggable diseases, primarily targeting cancer. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $120M | 2025-12-03 | [ PART ] |
Pelage Pelagepharma develops regenerative medicines focused on treating hair loss using stem cell technology. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $120M | 2025-10-15 | [ PART ] |
Neurona Therapeutics Cell therapies for targeted repair of dysfunctional neural circuits underlying chronic neurological diseases. | Funding round Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $102M | 2025-04-03 | [ PART ] |
No sector on record.